Searching map area
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
? TBD
scientific article
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Han van Krieken
Gerrit Meijer
Roland P Kuiper
Subject
Colorectal cancer
Cetuximab
microRNA
metastatic colon cancer
colorectal carcinoma
References
Wikidata